Nasdaq - Delayed Quote USD

Rydex Biotechnology C (RYCFX)

50.80 -0.37 (-0.72%)
At close: June 14 at 8:00 PM EDT
Loading Chart for RYCFX
DELL
  • Previous Close 51.17
  • YTD Return -2.06%
  • Expense Ratio 1.64%
  • Category Health
  • Last Cap Gain 42.00
  • Morningstar Rating
  • Morningstar Risk Rating High
  • Sustainability Rating
  • Net Assets 104.07M
  • Beta (5Y Monthly) 0.80
  • Yield 0.00%
  • 5y Average Return --
  • Holdings Turnover 51.00%
  • Last Dividend --
  • Inception Date Sep 1, 2004

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Rydex Funds

Fund Family

Health

Fund Category

104.07M

Net Assets

2004-09-01

Inception Date

Performance Overview: RYCFX

Trailing returns as of 6/14/2024. Category is Health.

YTD Return

RYCFX
2.06%
Category
7.95%
 

1-Year Return

RYCFX
6.44%
Category
30.16%
 

3-Year Return

RYCFX
3.35%
Category
16.10%
 

5-Year Return

RYCFX
4.99%
Category
15.71%
 

People Also Watch

Holdings: RYCFX

Top 10 Holdings (43.97% of Total Assets)

SymbolCompany% Assets
ABBV
AbbVie Inc. 8.82%
AMGN
Amgen Inc. 6.70%
REGN
Regeneron Pharmaceuticals, Inc. 5.10%
VRTX
Vertex Pharmaceuticals Incorporated 4.29%
GILD
Gilead Sciences, Inc. 3.70%
MRNA
Moderna, Inc. 3.47%
CTVA
Corteva, Inc. 3.30%
AZN
AstraZeneca PLC 3.29%
BIIB
Biogen Inc. 3.02%
ILMN
Illumina, Inc. 2.28%

Sector Weightings

SectorRYCFX
Healthcare   96.69%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Recent News: RYCFX

Research Reports: RYCFX

Top Mutual Funds